Published in

Elsevier, Digestive and Liver Disease, 4(52), p. 447-451, 2020

DOI: 10.1016/j.dld.2019.12.007

Elsevier, Journal of Hepatology, (68), p. S300-S301

DOI: 10.1016/s0168-8278(18)30819-5

Links

Tools

Export citation

Search in Google Scholar

Safety and efficacy of Daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA Foundation cohorts

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO